Home Deal Advisory Transaction Advisory Valuation Insights Begin a Conversation
Healthcare · Hospitals · Clinics · HealthTech · UAE & GCC M&A

M&A Advisory for Healthcare
Companies in the UAE

The UAE healthcare sector is one of the fastest-growing in the GCC — driven by UAE Vision 2031 health strategy, mandatory health insurance, growing medical tourism, and significant privatisation of healthcare delivery. Corvian Advisory provides specialist M&A advisory and independent valuation for UAE healthcare businesses, including hospitals, polyclinics, diagnostic centres, home care providers, dental chains, HealthTech, and pharma distributors. CFA-led. Fixed fee.

DHA & HAAD Licence Transfer Expertise
EV/EBITDA Healthcare Valuation
CFA Charterholder-Led
Fixed Fee — No Retainer Surprises
Healthcare M&A UAE Hospital Valuation Dubai Clinic Chain M&A GCC HealthTech UAE Diagnostic Centre Sale UAE Medical Tourism UAE DHA Licensed Business
Discuss Your Healthcare Business Get a Fixed Fee Quote
USD 30B+
UAE healthcare market size by 2028
DHA & HAAD
Licence expertise for business sales
CFA-Led
Principal-led from first call
Fixed Fee
Scope agreed before work begins
What We Do

M&A & Valuation Services for UAE Healthcare Companies

Healthcare M&A in the UAE demands sector-specific expertise that goes beyond financial modelling — licence transfer planning, payor mix analysis, consultant tenure risk, and an acquirer universe that spans PE funds, sovereign investors, hospital groups, and insurance companies. We understand both the clinical and commercial dynamics of UAE healthcare deals.

🏥

Healthcare Sell-Side Advisory

Full sell-side for UAE healthcare businesses (hospitals, clinic chains, home care, diagnostics) — valuation, CIM with healthcare KPIs (EBITDA margin, ARPU, bed occupancy, revenue per patient), structured outreach to PE, hospital groups, and GCC sovereign investors, through to close.

📊

Healthcare Business Valuation

IVS-compliant valuation using EV/EBITDA multiples (typically 6x–14x for UAE healthcare), DCF, and NAV. Includes DHA/HAAD licence value, patient database intangible, and brand value where applicable. Fixed fee.

🔍

Buy-Side — Acquiring a UAE Healthcare Business

Buy-side advisory for PE, hospital groups, and corporates acquiring UAE healthcare assets — target identification, clinical and financial due diligence coordination, licence transfer planning (DHA/HAAD/MOH), and deal structuring.

💻

HealthTech M&A & Valuation

M&A advisory and ARR-based valuation for UAE HealthTech businesses — EMR/EHR platforms, telehealth, hospital management software, digital health apps, and medtech. Growing acquirer universe of hospital groups, insurance companies, and GCC PE.

🔬

Financial Due Diligence — Healthcare

Buy-side FDD for healthcare acquisitions — revenue quality by payor mix (insurance vs self-pay vs government), working capital normalisation for medical consumables, regulatory compliance review (DHA, HAAD, MOH), and EBITDA normalisation for consultant fee structures.

🚀

Healthcare Fundraising Advisory

Capital raising for UAE healthcare businesses — equity and debt advisory for clinic roll-ups, hospital expansions, and HealthTech fundraising from GCC family offices, PE funds (Investcorp, Gulf Capital, Waha Capital), and sovereign-linked investors (Mubadala Health, ADQ).

Sector Insight

What Makes UAE Healthcare M&A Different

Healthcare M&A in the UAE has sector-specific nuances that general M&A advisors consistently underestimate. These are the deal dynamics that determine whether a transaction closes — and at what multiple.

01
Licence = Value
DHA and HAAD licences, and specialist consultant authorisations, are the most valuable intangibles in many UAE healthcare acquisitions. Licence transfer adds 60–90 days and requires MOH/DHA/HAAD approval. Not planning for this upfront is the most common reason UAE healthcare deals stall.
02
Insurance Mix Drives Multiple
Clinic chains and hospitals with a high proportion of Thiqa (HAAD) or Daman insurance revenue command a premium over pure self-pay businesses. Government and quasi-government insurance contracts are sticky, high-volume, and credible to acquirers — they directly lift the multiple.
03
GCC PE is Highly Active
Gulf Capital, Investcorp, Waha Capital, and Mubadala Health have all made significant UAE healthcare acquisitions. The sector is a preferred PE vertical due to its defensive revenue, population growth demand driver, and UAE government healthcare privatisation mandate.
04
Roll-Up Premium
UAE clinic chains (dental, physiotherapy, aesthetics, GP polyclinics) trade at a 30–50% premium to single-site businesses of the same EBITDA. Buyers pay for the operational platform, branded network, and the ability to add further sites under a proven management team. Founders with 3+ sites should position as a roll-up platform, not as individual clinics.
05
Medical Tourism Optionality
Dubai has invested significantly in becoming a regional medical tourism hub — particularly for oncology, orthopaedics, and cosmetic surgery. Hospitals and specialist clinics that serve medical tourism patients from across MENA, Africa, and the CIS command a premium for this diversified revenue base and the UAE's infrastructure advantage.
06
HealthTech Acquirers Are Expanding
The acquirer universe for UAE HealthTech has broadened materially — hospital groups acquiring EMR and telehealth platforms, insurance companies acquiring health data and preventative care technology, and global HealthTech firms acquiring MENA-specific regulatory knowledge. NABIDH (Dubai Health Authority data framework) compliance is increasingly an acquirer requirement.
FAQs

Healthcare M&A FAQs

How are healthcare businesses valued in the UAE?+
EV/EBITDA (6x–14x depending on type — hospital groups at the top, single-site clinics at the lower end), DCF for larger businesses with multi-year contracts, and NAV for asset-heavy hospital facilities. Key value drivers: payor mix (insurance vs self-pay), bed/room occupancy rates, EBITDA margin vs sector peers, DHA/HAAD licence seniority, consultant tenure and exclusivity, and organic vs acquisitive growth profile. Corvian Advisory benchmarks UAE healthcare valuations against GCC precedent transactions and global emerging-market healthcare M&A.
Who acquires healthcare businesses in the UAE?+
The UAE healthcare acquirer universe includes: GCC PE funds (Gulf Capital, Investcorp, Waha Capital, Al Wasat) which are the most active financial buyers; sovereign-linked investors (Mubadala Health, ADQ's healthcare portfolio); UAE and GCC hospital groups (NMC Health successors, Aster DM, King's College Hospital Dubai, Burjeel) pursuing consolidation; global hospital groups (IHH, Apollo, Mediclinic) with MENA expansion mandates; and insurance companies acquiring healthcare delivery assets for vertical integration.
What licences are required to sell a healthcare business in the UAE?+
Healthcare business sales in the UAE require DHA (Dubai), HAAD (Abu Dhabi), or MOH approval for the licence transfer to the acquirer. The clinic or hospital licence, individual consultant authorisations, and pharmacy licences (if applicable) all require separate transfer or re-application. Corvian Advisory structures sell-side healthcare mandates with licence transfer timelines built into the process from day one.
What is the M&A market like for dental and aesthetics clinics in the UAE?+
Dental chains and aesthetics clinics are among the most actively traded healthcare assets in the UAE, driven by strong consumer demand, high margins, and the roll-up opportunity across the fragmented UAE market. EV/EBITDA multiples for branded dental chains range from 7x to 12x. Key value drivers: branded name recognition, DHA-licensed consultant roster, patient retention data, and number of chairs/treatment rooms as a capacity proxy.
Can Corvian Advisory value a HealthTech business for fundraising?+
Yes. Corvian Advisory values UAE HealthTech businesses using ARR multiples, DCF, or revenue multiples depending on the stage and business model — applied consistently with comparable global and MENA HealthTech transactions. Reports are prepared by a CFA Charterholder and are accepted by GCC investors, PE funds, and institutional counterparties.
Other Industries: Technology & SaaS FinTech Real Estate Logistics Food & Beverage Consumer & Retail Industrial

Selling or Acquiring a UAE Healthcare Business?

CFA-led M&A advisory and independent healthcare business valuation. Fixed fee. DHA, HAAD, and MOH licence transfer expertise included.

Discuss Your Healthcare Business WhatsApp for Fast Quote